Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis
NCT04582331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-05-14
Summary
This is a confirmatory study that seeks to examine whether respiratory-responsive vocal biomarkers have potential to respond to COVID-19 infection status and respiratory symptom severity. Patients with suspected COVID-19 and healthy controls will submit daily voice samples and symptom inventories on their personal smartphone devices for 14 days.
Conditions
- Covid19
Interventions
- OTHER
-
Smartphone-based voice and self-reported symptom collection
Voice samples and COVID-19 symptom inventories will be collected on participant smartphone devices. No outcomes or feedback is provided on acquired data during trial conduct but will be used for confirmatory data analysis post study
Sponsors & Collaborators
-
Sonde Health
lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-10
- Primary Completion
- 2021-05-12
- Completion
- 2021-05-12
Countries
- United States
- India
Study Locations
More Related Trials
-
Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study
NCT06006611 ·Status: UNKNOWN
-
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19
NCT04594343 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER)
NCT04399109 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS
NCT04582201 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
NCT04522830 ·Status: COMPLETED ·Phase: PHASE2
-
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
NCT02845843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of S-892216 in Participants With COVID-19
NCT06928051 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
NCT04537208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
NCT04405076 ·Status: COMPLETED ·Phase: PHASE2
-
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning
NCT06052527 ·Status: COMPLETED
-
Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
NCT00073086 ·Status: WITHDRAWN
-
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
NCT04593641 ·Status: COMPLETED ·Phase: PHASE1
-
A Simple Approach to Prevent Hospitalization for COVID-19 Patients
NCT04854824 ·Status: COMPLETED
-
Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
NCT04244591 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
NCT04395391 ·Status: COMPLETED
-
Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients
NCT04584606 ·Status: UNKNOWN
-
A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
NCT04458298 ·Status: TERMINATED ·Phase: PHASE2
-
Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test
NCT04782336 ·Status: SUSPENDED ·Phase: NA
-
Impact of Rapid Flu Testing in BMC ED
NCT02979730 ·Status: COMPLETED ·Phase: NA
-
Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19
NCT04949074 ·Status: COMPLETED
-
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
NCT04758273 ·Status: UNKNOWN ·Phase: PHASE1
-
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
NCT04320238 ·Status: UNKNOWN ·Phase: PHASE3
-
FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
NCT05928507 ·Status: UNKNOWN
-
Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia
NCT04679350 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient
NCT04595136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2